View More View Less
  • 1 Országos Onkológiai Intézet, Budapest
  • 2 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
  • 3 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
Open access

Absztrakt:

A májtranszplantáció eredményei az elmúlt évtizedekben jelentősen javultak. Egyre több beteg számára jelent életmentő kezelést a májátültetés, miközben az indikációk köre is változik. A világszerte fennálló szervhiány azonban új stratégiák kidolgozására készteti a szakmát. A donorkritériumok észszerű kiterjesztésével, precízebb szervallokációval, személyre szabott donációval, élődonációval, gépi perfúzió alkalmazásával és a szívmegállást követő donáció bevezetésével új távlatok nyílnak, amelyek eredményeként a májtranszplantáció egyre több végstádiumú májbeteg számára válhat elérhetővé. Összefoglaló közleményünkben az új lehetőségeket és kihívásokat mutatjuk be a magyarországi májtranszplantációs program tükrében. Orv Hetil. 2019; 160(29): 1127–1135.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Gastaca M. Extended criteria donors in liver transplantation: adapting donor quality and recipient. Transplant Proc. 2009; 41: 975–979.

  • 2

    Statistics Report Library. Eurotransplant, Leiden. Available from: statistics.eurotransplant.org [accessed: January 20, 2019].

  • 3

    Neves DB, Rusi MB, Diaz LG, et al. Primary graft dysfunction of the liver: definitions, diagnostic criteria and risk factors. Einstein (Sao Paulo) 2016; 14: 567–572.

  • 4

    Hoyer DP, Paul A, Gallinat A, et al. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. Liver Int. 2015; 35: 156–163.

  • 5

    Mathé Z, Paul A, Molmenti EP, et al. Liver transplantation with donors over the expected lifespan in the model for end-staged liver disease era: is Mother Nature punishing us? Liver Int. 2011; 31: 1054–1061.

  • 6

    Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006; 6: 783–790.

  • 7

    Barshes NR, Horwitz IB, Franzini L, et al. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant. 2007; 7: 1265–1270.

  • 8

    Bolondi G, Mocchegiani F, Montalti R, et al. Predictive factors of short term outcome after liver transplantation: a review. World J Gastroenterol. 2016; 22: 5936–5949.

  • 9

    Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, et al. Predictive power of Model for End-Stage Liver Disease and Child–Turcotte–Pugh score for mortality in cirrhotic patients. Clin Exp Hepatol. 2018; 4: 240–246.

  • 10

    Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation 2006; 82: 1653–1657.

  • 11

    Nemes B, Gelley F, Zádori G, et al. Outcome of liver transplantation based on donor graft quality and recipient status. Transplant Proc. 2010; 42: 2327–2330.

  • 12

    Schmitz S, Lurje G, Ulmer F, et al. Loco-regional hepatocellular carcinoma treatment services as a bridge to liver transplantation. Hepatobiliary Pancreat Dis Int. 2019; 18: 228–236.

  • 13

    Yersiz H, Shaked A, Olthoff K, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995; 60: 790–794.

  • 14

    Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl. 2003; 9: 500–505.

  • 15

    de Graaf EL, Kench J, Dilworth P, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol. 2012; 27: 540–546.

  • 16

    Chavin KD, Taber DJ, Norcross M, et al. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013; 27: 732–741.

  • 17

    Imber CJ, St Peter SD, Handa A, et al. Hepatic steatosis and its relationship to transplantation. Liver Transpl. 2002; 8: 415–423.

  • 18

    Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202–210.

  • 19

    Coordinating organ donation in Germany. German Organ Transplantation Foundation. [Koordinierung der Organspende in Deutschland. Deutsche Stiftung Organtransplantation.] Frankfurt am Main. Available from: http://www.dso.de [accessed: January 14, 2017] [German]

  • 20

    Dirican A, Soyer V, Koc S, et al. Transplantation with livers from octogenarians and a nonagenarian. Transplant Proc. 2015; 47: 1323–1325.

  • 21

    Sutherland AI, IJzermans JN, Forsythe JL, et al. Kidney and liver transplantation in the elderly. Br J Surg. 2016; 103: 62–72.

  • 22

    Durand F, Renz JF, Alkofer B, et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl. 2008; 14: 1694–1707.

  • 23

    Radunz S, Paul A, Nowak K, et al. Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go? Liver Int. 2011; 31: 1021–1027.

  • 24

    Fagiuoli S, Ravasio R, Lucà MG, et al. Management of hepatitis C infection before and after liver transplantation. World J Gastroenterol. 2015; 21: 4447–4456.

  • 25

    Manzarbeitia C, Reich DJ, Ortiz JA, et al. Safe use of livers from donors with positive hepatitis B core antibody. Liver Transpl. 2002; 6: 556–561.

  • 26

    Naggie S. Treating HCV infection: it doesn’t get much better than this. Top Antivir Med. 2019; 26: 104–108.

  • 27

    Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 26 March 2018. [Hepatitis C-vírus fertőzés szűrése, diagnosztikája, antivirális terápiája, kezelés utáni gondozása. Magyar konszenzusajánlás. Érvényes: 2018. március 26-tól.] Available from: https://hepreg.hu/custom/hepreg/doc/HCV_konszenzus_ajanlas_2018_marcius_v7.pdf [accessed: January 12, 2019]. [Hungarian]

  • 28

    Bowring MG, Kucirka LM, Massie AB, et al. Changes in utilization and discard of hepatitis C-infected donor livers in the recent era. Am J Transplant 2017; 17: 519–527.

  • 29

    Nemes B, Gámán G, Polak WG, et al. Extended-criteria donors in liver transplantation. Part II: Reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Expert Rev Gastroenterol Hepatol. 2016; 10: 841–859.

  • 30

    Nemes B, Gámán G, Polak WG, et al. Extended criteria donors in liver transplantation. Part I: Reviewing the impact of determining factors. Expert Rev Gastroenterol Hepatol. 2016; 10: 827–839.

  • 31

    Cerutti E, Stratta C, Romagnoli R, et al. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl. 2006; 12: 1253–1259.

  • 32

    Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000; 70: 1747–1751.

  • 33

    Desai R, Neuberger J. Donor transmitted and de novo cancer after liver transplantation. World J Gastroenterol. 2014; 20: 6170–6179.

  • 34

    Cherqui D, Soubrane O, Husson E, et al. Laparoscopic living donor hepatectomy for liver transplantation in children. Lancet 2002; 359: 392–396.

  • 35

    Máthé Z, Kóbori L, Görög D, et al. The first successful adult right-lobe living donor liver transplantation in Hungary. [Az első sikeres élő donoros felnőttkori jobb lebenyes májtranszplantáció Magyarországon.] Orv Hetil. 2010; 151: 3–7. [Hungarian]

  • 36

    Doyle MB, Maynard E, Lin Y, et al. Outcomes with split liver transplantation are equivalent to those with whole organ transplantation. J Am Coll Surg. 2013; 217: 102–112.

  • 37

    Cauley RP, Vakili K, Fullington N, et al. Deceased-donor split-liver transplantation in adult recipients: is the learning curve over? J Am Coll Surg. 2013; 217: 672–684.

  • 38

    Merion RM, Rush SH, Dykstra DM, et al. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant. 2004; 4: 1792–1797.

  • 39

    Chen CL, Kabiling CS, Concejero AM. Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol. 2013; 10: 746–751.

  • 40

    Fisher RA. Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol. 2017; 14: 373–382.

  • 41

    Newsletter Transplant. International figures on donation and transplantation, 2017. Dansk Center for Organdonation, Aarhus. Available from: http://www.transplant-observatory.org/download/6732/ [accessed: December 2018].

  • 42

    Hoyer DP, Klein C, Kathemann S, et al. Left-lateral living related liver donation – the Essen experience. [Bal oldali élő májdonáció. Esseni tapasztalatok.] Zentralbl Chir. 2016; 141: 570–576. [German]

  • 43

    Lauterio A, Di Sandro S, Concone G, et al. Current status and perspectives in split liver transplantation. World J Gastroenterol. 2015; 21: 11003–11015.

  • 44

    Guidelines for the determination of death. Report of the medical consultants on the diagnosis of death to the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Conn Med. 1982; 46: 207–210.

  • 45

    Martin K, Allen E, Johnson R. Annual report on liver transplantation. Report for 2014/2015 (1 April 2005–31 March 2015). Statistics and Clinical Studies, NHS Blood and Transplant, September 2015. Available from: http://odt.nhs.uk/pdf/organ_specific_report_liver_2015.pdf [accessed: February 20, 2017].

  • 46

    Selck FW, Grossman EB, Ratner LE, et al. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008; 248: 599–607.

  • 47

    de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009; 9: 773–781.

  • 48

    Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009; 15: 1028–1035.

  • 49

    Schaubel DE, Sima CS, Goodrich NP, et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant. 2008; 8: 419–425.

  • 50

    Massicotte L, Thibeault L, Roy A. Classical notions of coagulation revisited in relation with blood losses, transfusion rate for 700 consecutive liver transplantations. Semin Thromb Hemost. 2015; 41: 538–546.

  • 51

    Hoyer DP, Mathé Z, Gallinat A, et al. Controlled oxygenated rewarming of cold stored livers prior to transplantation: first clinical application of a new concept. Transplantation 2016; 100: 147–152.

  • 52

    Minor T, Pütter C, Gallinat A, et al. Oxygen persufflation as adjunct in liver preservation (OPAL): study protocol for a randomized controlled trial. Trials 2011; 12: 234.

  • 53

    Weeder PD, van Rijn R, Porte RJ. Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: rationale, current evidence and future directions. J Hepatol. 2015; 63: 265–275.

  • 54

    Wettstein D, Hamar M, Cseprekál O, et al. Machine perfusion: new opportunities in abdominal organ transplantation. [Szervkonzerválás gépi perfúzióval: új lehetőségek a hasi szervek transzplantációjában.] Orv Hetil. 2018; 159: 1882–1890. [Hungarian]

  • 55

    Karangwa SA, Dutkowski P, Fontes P, et al. Machine perfusion of donor livers for transplantation: a proposal for standardized nomenclature and reporting guidelines. Am J Transplant. 2016; 16: 2932–2942.

  • 56

    Nasralla D, Coussios CC, Mergental H, et al. Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature 2018; 557(7703): 50–56.

  • 57

    Cowan PJ, Tector AJ. The resurgence of xenotransplantation. Am J Transplant. 2017; 17: 2531–2536.

  • 58

    Ibars EP, Cortes M, Tolosa L, et al. Hepatocyte transplantation program: lessons learned and future strategies. World J Gastroenterol. 2016; 22: 874–886.

  • 59

    Volk ML, Goodrich N, Lai JC, et al. Decision support for organ offers in liver transplantation. Liver Transpl. 2015; 21: 784–791.

  • 60

    Trunecka P, Gerlei Z, Lisik W, et al. Liver transplantation in Central Europe. Clin Exp Hepatol. 2016; 2: 21–26.

  • 61

    Branger P, Samuel U. (eds.) Annual report 2017. Eurotransplant International Foundation, Leiden. Available from: http://www.eurotransplant.org/cms/mediaobject.php?file=Annual+Report+2017+HR10.pdf [accessed: January 14, 2019].

  • 62

    Hungarian National Blood Transfusion Service. Basic data of donation and transplantation in Hungary. [Országos Vérellátó Szolgálat: Donációs-transzplantációs alapadatok.] Available from: http://www.ovsz.hu/oco/donacios-transzplantacios-alapadatok [accessed: January 14, 2019]. [Hungarian]

  • 63

    European Liver Transplant Registry. Available from: http://www.eltr.org/HGBUDA.html [accessed: November 17, 2018].

  • Impact Factor (2018): 0.564
  • Medicine (miscellaneous) SJR Quartile Score (2018): Q3
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

Mendeley citation style is available HERE.

 

MANUSCRIPT SUBMISSION